Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SURE-HF Trial
NCT07631780Not yet recruiting
- Start
- Jun 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Randomised, open-label trial of furosemide in heart failure (HF) (4 arms). Primary endpoint: Hierarchical Composite Endpoint of Unsuccessful Decongestion up to 14 days. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
furosemide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT07631780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07631780.